Iluka Resources Limited (ASX:ILU)
Australia · Delayed Price · Currency is AUD 5.32
+0.11 (2.11%)
Aug 4, 2025, 4:10 PM AEST
Verve Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 136 | 364.9 | 521.7 | 294.8 | 87.1 | Upgrade |
Cash & Short-Term Investments | 136 | 364.9 | 521.7 | 294.8 | 87.1 | Upgrade |
Cash Growth | -62.73% | -30.06% | 76.97% | 238.46% | -10.48% | Upgrade |
Accounts Receivable | 268.1 | 254.8 | 248 | 213.8 | 55 | Upgrade |
Other Receivables | 22.6 | 12 | 8 | 16.5 | 26.6 | Upgrade |
Receivables | 290.7 | 266.8 | 256 | 230.3 | 81.6 | Upgrade |
Inventory | 839.4 | 662.7 | 543.3 | 489.7 | 504.1 | Upgrade |
Prepaid Expenses | 15.2 | 16.3 | 19.1 | 23.4 | 13.9 | Upgrade |
Other Current Assets | - | 2.6 | - | - | 1.9 | Upgrade |
Total Current Assets | 1,281 | 1,313 | 1,340 | 1,038 | 688.6 | Upgrade |
Property, Plant & Equipment | 1,707 | 1,352 | 1,139 | 1,038 | 1,082 | Upgrade |
Long-Term Investments | 454.1 | 461.3 | 469.5 | 455.7 | 452.1 | Upgrade |
Long-Term Deferred Tax Assets | 94.2 | 62.1 | 35 | 39.1 | 28.4 | Upgrade |
Other Long-Term Assets | 205 | 142 | 18.3 | 65 | 112.6 | Upgrade |
Total Assets | 3,741 | 3,331 | 3,002 | 2,636 | 2,364 | Upgrade |
Accrued Expenses | 18.9 | 17 | 14.7 | 18.9 | 17.7 | Upgrade |
Current Portion of Leases | 12.6 | 8.4 | 8.9 | 8.7 | 7.5 | Upgrade |
Current Income Taxes Payable | 26.7 | 39.6 | 135.3 | 28.5 | 29.3 | Upgrade |
Other Current Liabilities | 258.8 | 222.7 | 214.9 | 256.5 | 206.7 | Upgrade |
Total Current Liabilities | 317 | 287.7 | 373.8 | 312.6 | 261.2 | Upgrade |
Long-Term Debt | 250.6 | 139.5 | 33 | - | 36.9 | Upgrade |
Long-Term Leases | 28.1 | 15.8 | 20.6 | 27.2 | 15.8 | Upgrade |
Other Long-Term Liabilities | 777 | 721.6 | 672 | 675.2 | 730.9 | Upgrade |
Total Liabilities | 1,381 | 1,172 | 1,107 | 1,042 | 1,072 | Upgrade |
Common Stock | 1,160 | 1,144 | 1,133 | 1,156 | 1,152 | Upgrade |
Retained Earnings | 1,191 | 993.9 | 748.6 | 413.9 | 104.3 | Upgrade |
Treasury Stock | -1.4 | -0.7 | -2.9 | -7.2 | -1.2 | Upgrade |
Comprehensive Income & Other | 11.2 | 21.4 | 16.6 | 31 | 37.1 | Upgrade |
Total Common Equity | 2,360 | 2,159 | 1,895 | 1,593 | 1,292 | Upgrade |
Minority Interest | - | - | - | 1.4 | 0.4 | Upgrade |
Shareholders' Equity | 2,360 | 2,159 | 1,895 | 1,595 | 1,292 | Upgrade |
Total Liabilities & Equity | 3,741 | 3,331 | 3,002 | 2,636 | 2,364 | Upgrade |
Total Debt | 291.3 | 163.7 | 62.5 | 35.9 | 60.2 | Upgrade |
Net Cash (Debt) | -155.3 | 201.2 | 459.2 | 258.9 | 26.9 | Upgrade |
Net Cash Growth | - | -56.18% | 77.37% | 862.45% | 102.26% | Upgrade |
Net Cash Per Share | -0.36 | 0.47 | 1.09 | 0.61 | 0.06 | Upgrade |
Filing Date Shares Outstanding | 427.87 | 425.93 | 424.46 | 421.99 | 422.57 | Upgrade |
Total Common Shares Outstanding | 427.87 | 425.93 | 424.46 | 421.99 | 422.57 | Upgrade |
Working Capital | 964.3 | 1,026 | 966.3 | 725.6 | 427.4 | Upgrade |
Book Value Per Share | 5.52 | 5.07 | 4.46 | 3.78 | 3.06 | Upgrade |
Tangible Book Value | 2,360 | 2,159 | 1,895 | 1,593 | 1,292 | Upgrade |
Tangible Book Value Per Share | 5.52 | 5.07 | 4.46 | 3.78 | 3.06 | Upgrade |
Land | 202.1 | 187.7 | 196.8 | 311.8 | 300.5 | Upgrade |
Machinery | 2,747 | 2,303 | 2,120 | 2,441 | 2,355 | Upgrade |
Construction In Progress | - | - | - | 52.1 | 27.5 | Upgrade |
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.